Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rukshen Weerasooriya

Prof Rukshen Weerasooriya

ECG Cases with Traces

Dr David Yeo

Dr David Yeo

Gallbladder – When Surgery Is Or Is Not Needed

Dr Susannah Graham & Dr Sanjeev Kumar

Dr Susannah Graham & Dr Sanjeev Kumar

Panel Discussion on Adjuvant Hormone Therapy Post Breast Cancer

Dr Peter Lin

Dr Peter Lin

Covid-19 Infection – What We Know Now

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024